EXCLUSIVE: Banks Asks FTC to Investigate Abortion Drug Manufacturers 

There’s No Academic Freedom to Incite Hatred

PoliticsSocietyCommentary

How Will SCOTUS Respond to NJ Tightening Its Hold on Nonprofits?

AI Isn’t the Future of Our National Security. It’s the Present.

American Immigration Policy Could Learn From Modern Italy, Ancient Rome, and Plato

EXCLUSIVE: CBP Makes Massive Cocaine Seizure From Bus

Gill Blasts Republicans Who Voted to Keep Protected Status for Haitians

   PoliticsSecuritySocietyNews

‘16 Years Is Not Temporary’: Freedom Caucus Members Want TPS Ended for Haitians

AI Isn’t the Future of Our National Security. It’s the Present.

Iran Crumbles, Critics Scramble: Trump’s Long Game Leaves the Media Exposed

 LawPoliticsSocietyNews

Heritage Panel: CCP is Murdering Citizens for Organs and Profiting by the Billions

How China Dominates the World’s Critical Minerals Production

Campaigns Make Use of AI in Attacks

How Taxes Affect Ohioans on April 15 and Beyond

RFK Jr. Defends HHS Agenda on Capitol Hill, Touts Early Wins and Future Reforms

FISA Spy Powers Vote a Late-Night Trainwreck on House Floor

DOJ’s Harmeet Dhillon Details Just How Much of a ‘Mess’ Voter Rolls Are

Virginia Voters Should Look to Democrat-Run Maryland on Redistricting

Ruling Allows Fulton County to Block Republican Election Board Nominees 

Spanberger Is ‘Taking Credit’ for Youngkin’s Economic Deals

Trump Bullish on Iran Deal, but Uncertainty Remains

Where Do Dem Presidential Favorites Stand on Israel?

 PoliticsSecurityNews

Trump Claims Gold Star Families Told Him to ‘Finish the Job’ in Iran

Citing ‘Echo Chamber’ on Iran, Trump Counterterrorism Chief Resigns

Conservative and Proud: Is the Right Representing Women? 

Girl Boss vs. Trad Wife: Forced to Choose?

Beyond the Oyster Fork: An Etiquette Expert’s Tips for ‘Relationships, Work, and Life’

Is the Iran Operation ‘America First’?

The Implosion of Eric Swalwell: What Was He Thinking?

International Commentary

How Trump Outsmarted Iran While Critics Rooted Against America and the Media Melted Down

Victor Davis Hanson Calls Out MAGA’s New ‘Defectors’

Democrats’ Jungle Primary Boomerang Hits Swalwell Hard

EXCLUSIVE: Banks Asks FTC to Investigate Abortion Drug Manufacturers 

Sen. Jim Banks, R-Ind. (Bill Clark/CQ-Roll Call, Inc via Getty Images)

Pedro Boccalato Rodriguez-Aparicio is a journalism fellow at The Daily Signal. Send an email to Pedro.

FIRST ON THE DAILY SIGNAL — Indiana Sen. Jim Banks urged the Federal Trade Commission on Monday to investigate abortion drug manufacturers and distributors for potentially false or misleading medical and safety claims.

In a letter to the FTC, Banks called on the commission to uphold federal prohibitions against deceptive trade practices by holding abortion drug companies to the same standards as other companies.

“Mifepristone manufacturers and dispensers continue to mislead pregnant women into thinking that abortion drugs are much safer than they really are, and that even if something bad does happen, they can receive appropriate treatment without disclosing their abortion,” the letter stated.

“Companies that profit from abortion drugs should be honest about their risks,” the letter added. “The FTC has the tools in its toolbox to hold abortion drug companies to their obligations under consumer protection law.”

Banks said that medication abortion, involving the drugs mifepristone and misoprostol, accounts for nearly two-thirds of all abortions in the United States. He noted that these drugs are often prescribed online, without in-person screening for dangerous complications such as ectopic pregnancy. They are then shipped nationwide, including into states that have restricted abortion.

Banks took issue with marketing claims that mifepristone is “safer than Tylenol” or other common over-the-counter medications.

“There is no scientific basis for the claim that mifepristone is ‘safer than Tylenol,'” Banks wrote, arguing that such claims lack the standards of controlled studies and could thus constitute deceptive trade practices under FTC precedent.

Banks’ letter cites a report by the Ethics and Public Policy Center that, according to insurance claims data, more than 10% of women who take the abortion pill experience serious adverse events, including hemorrhaging and sepsis.

The letter references the death of Amber Thurman, a 28-year-old Georgia mother who died after suffering septic shock “due to complications from mifepristone.”

Some clinics advise women to tell emergency room staff they are experiencing a miscarriage rather than disclose an abortion, while asserting—without proper evidence, the letter says—that the treatments are the same for both.

“According to various clinics, women who receive emergency treatment following a chemical abortion can get the care they need without mentioning the abortion,” Banks stated. “Some clinics even claim that the treatment for chemical abortion complications is the same as treatment for miscarriage.”

The senator emphasizes that federal law, as interpreted by the Federal Trade Commission, prohibits claims “that are likely to reasonably mislead consumers to their detriment.”

HHS Scraps Biden-Era Abortion Pill Mandate for Pharmacies

‘We Must Hold the Line and Support ICE’: House Republicans Say Schumer’s Demands Are ‘Nonstarter’

WOKE INFILTRATION: The Deep Scandal Behind the Biden DOJ Targeting Pro-Lifers

Read the first chapter of The Woketopus right now for FREE

Today, even with President Trump’s victory, leftist elites have their tentacles in every aspect of our government.

The Daily Signal’s own Tyler O’Neil exposes this leftist cabal in his new book, The Woketopus: The Dark Money Cabal Manipulating the Federal Government.

In this book, O’Neil reveals how the Left’s NGO apparatus pursues its woke agenda, maneuvering like an octopus by circumventing Congress and entrenching its interests in the federal government.

You can read the first chapter of this new book for FREE in this eBook, The Woketopus: Chapter One using the secure link below.

The Tony Kinnett Cast

The Daily Signal Podcast

© 2025 The Daily Signal Media Group, Inc. All rights reserved.

We use cookies on our website. By using our website, you consent to cookies.  Learn More .  

© The Daily Signal